Article
Proteomic strategies in bladder cancer.
IUBMB life - 1 Jul 1999
Celis J E, Wolf H, Ostergaard M
Abstract excerpt
Here we review our current strategy for identifying phenotypic changes in the urothelium of bladder cancer patients with invasive disease, using a combination of proteomic technologies and immunowalking. This approach, which in principle can be applied to the study of any type of bladder cancer, makes use of proteomic technologies (for more information see http://biobase.dk/cgi-bin/celis) to reveal and identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
